Asaf Danziger
2018
In 2018, Asaf Danziger earned a total compensation of $4.6M as Chief Executive Officer at NovoCure, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $644,266 |
|---|---|
| Option Awards | $2,359,400 |
| Salary | $692,675 |
| Stock Awards | $587,505 |
| Other | $286,448 |
| Total | $4,570,294 |
Danziger received $2.4M in option awards, accounting for 52% of the total pay in 2018.
Danziger also received $644.3K in non-equity incentive plan, $692.7K in salary, $587.5K in stock awards and $286.4K in other compensation.
Rankings
In 2018, Asaf Danziger's compensation ranked 2,296th out of 14,244 executives tracked by ExecPay. In other words, Danziger earned more than 83.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,296 out of 14,244 | 84th |
Division Manufacturing | 838 out of 5,765 | 86th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 98 out of 849 | 89th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 46 out of 547 | 92nd |
Industry Surgical and Medical Instruments and Apparatus | 24 out of 348 | 93rd |
Source: SEC filing on April 10, 2019.
Danziger's colleagues
We found five more compensation records of executives who worked with Asaf Danziger at NovoCure in 2018.